Dr. Lang was awarded the New Investigator Program award from The Wisconsin Partnership Program (WPP). The grants were awarded to eight SMPH investigators for projects across the spectrum of basic, clinical, and translational research. Dr. Lang’s project, titled “Functional and Genomic Comparison of Ovarian Cancer Cells in Ascites to Primary Tumor and Associated Cell-free DNA”, aims to transform ovarian cancer care by repurposing tumor cell-containing abdominal fluid (ascites) samples from patients to identify markers of treatment resistance. The ability to easily assess risk of resistance in patients would potentially eliminate the use of ineffective therapy and serve as a signal for determining when second-line therapies should be explored.
See the official announcement: Wisconsin Partnership Program Awards $1.2 Million through New Investigator Program